STOCK TITAN

BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings clinical trial

BioMarin (NASDAQ: BMRN) announced a conference call and webcast with Alexander Hardy, president and CEO, on Monday, October 27, 2025 at 4:30 p.m. ET to discuss third quarter 2025 financial results and provide a general business update.

Dial-in numbers are provided for U.S./Canada and international participants, and a live audio webcast will be available via the investor site at https://investors.biomarin.com/. A replay will be archived on the site for one week following the call.

BioMarin (NASDAQ: BMRN) ha annunciato una conference call e una webcast con Alexander Hardy, presidente e amministratore delegato, lunedì 27 ottobre 2025 alle 16:30 ora dell'Est per discutere risultati finanziari del terzo trimestre 2025 e fornire un aggiornamento generale sull'andamento dell'azienda.

I numeri per la connessione telefonica sono disponibili per partecipanti Stati Uniti/Canada e internazionali, e una trasmissione audio in diretta sarà disponibile tramite il sito degli investitori su https://investors.biomarin.com/. Un replay sarà archiviato sul sito per una settimana successiva alla chiamata.

BioMarin (NASDAQ: BMRN) anunció una conferencia telefónica y webcast con Alexander Hardy, presidente y director ejecutivo, el lunes 27 de octubre de 2025 a las 4:30 p.m. (hora del Este) para discutir los resultados financieros del tercer trimestre de 2025 y proporcionar una actualización general del negocio.

Se proporcionan números de marcación para participantes de EE. UU./Canadá e internacionales, y habrá un webcast de audio en directo disponible a través del sitio para inversores en https://investors.biomarin.com/. Una repetición quedará archivada en el sitio durante una semana después de la llamada.

BioMarin (NASDAQ: BMRN)은 Alexander Hardy 사장 겸 최고경영자와의 컨퍼런스 콜 및 웹캐스트를 2025년 10월 27일 월요일 오후 4시 30분(동부 표준시)에 발표하여 2025년 3분기 재무 실적 및 일반 사업 업데이트를 논의합니다.

dial-in 번호는 미국/캐나다 및 국제 참가자를 위해 제공되며, 라이브 오디오 웹캐스트는 투자자 사이트 https://investors.biomarin.com/를 통해 이용할 수 있습니다. 재생은 콜 이후 일주일 동안 사이트에 보관됩니다.

BioMarin (NASDAQ: BMRN) a annoncé une conférence téléphonique et une webdiffusion avec Alexander Hardy, président et PDG, lundi 27 octobre 2025 à 16h30, heure de l'Est pour discuter des résultats financiers du troisième trimestre 2025 et fournir une mise à jour générale sur l'activité.

Des numéros d'accès sont fournis pour les participants États-Unis/Canada et internationaux, et une diffusion audio en direct sera disponible via le site des investisseurs à https://investors.biomarin.com/. Un enregistrement sera archivé sur le site pendant une semaine après l'appel.

BioMarin (NASDAQ: BMRN) kündigte einen Conference Call und Webcast mit Alexander Hardy, Präsident und CEO, Montag, der 27. Oktober 2025 um 16:30 Uhr ostamerikanischer Zeit an, um die Finanzergebnisse des dritten Quartals 2025 zu besprechen und ein allgemeines Unternehmensupdate zu geben.

Dial-in-Nummern werden für US/Canada und internationale Teilnehmer bereitgestellt, und ein Live-Audio-Webcast wird über die Investorenseite unter https://investors.biomarin.com/ verfügbar sein. Eine Aufzeichnung wird eine Woche nach dem Anruf auf der Seite archiviert.

بيو مارين (بورصة ناسداك: BMRN) أعلنت عن مكالمة جماعية وتسجيل ويب مع ألكسندر هاردي، الرئيس التنفيذي والمدير العام، الإثنين 27 أكتوبر 2025 الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة لمناقشة نتائج الربع الثالث من 2025 وتقديم تحديث عام للأعمال.

توفر أرقام الاتصال للمشاركين من الولايات المتحدة/كندا وللمشاركين الدوليين، وسيكون هناك بث صوتي مباشر عبر موقع المستثمرين على https://investors.biomarin.com/. سيُ archive وسيتم حفظ إعادة العرض على الموقع لمدة أسبوع واحد بعد الاتصال.

BioMarin(纳斯达克股票代码:BMRN)宣布将与总裁兼首席执行官Alexander Hardy进行电话会议和网络广播,时间为2025年10月27日星期一东部时间下午4:30,以讨论2025年第三季度财务业绩并提供公司一般业务更新。

美国/加拿大及国际参与者均可使用拨入号码,且现场音频网络广播可通过投资者网站访问:https://investors.biomarin.com/。回放将在电话会议结束后一周内在该网站存档。

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., Oct. 22, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, October 27, 2025, at 4:30 p.m. ET to discuss third quarter 2025 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 4998437 

U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 4998437 

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com

Contacts:


Investors                                                     

Media

Traci McCarty                              

Marni Kottle

BioMarin Pharmaceutical Inc.                       

BioMarin Pharmaceutical Inc.

(415) 455-7558                                               

(650) 374-2803

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2025-financial-results-conference-call-and-webcast-on-monday-october-27-2025-at-430pm-et-302590758.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin (BMRN) discuss its third quarter 2025 results?

BioMarin will hold a conference call and webcast on October 27, 2025 at 4:30 p.m. ET.

Who will host the BioMarin (BMRN) Q3 2025 earnings call?

The call will be hosted by Alexander Hardy, president and chief executive officer.

How can investors access the BioMarin (BMRN) earnings webcast on October 27, 2025?

Access the live audio webcast via the investor section at https://investors.biomarin.com/.

What are the dial-in numbers for the BioMarin (BMRN) October 27, 2025 conference call?

U.S./Canada dial-in is 800-715-9871; international dial-in is 646-307-1963; Conference ID 4998437.

Will there be a replay of the BioMarin (BMRN) Q3 2025 call and for how long?

Yes. A replay will be archived on the investor site for one week after the call; replay dial-ins are provided.

Where can I find the replay dial-in numbers for the BioMarin (BMRN) October 27 call?

U.S./Canada replay dial-in is 800-770-2030; international replay dial-in is 609-800-9909; playback ID 4998437.
Biomarin Pharmaceutical Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Latest SEC Filings

BMRN Stock Data

10.33B
190.52M
0.78%
98.97%
3.1%
Biotechnology
Pharmaceutical Preparations
Link
United States
NOVATO